Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Short-term exposure to enrofloxacin induces hepatic metabolism disorder associated with gut microbiota dysbiosis in adult marine medaka (Oryzias melastigma)

PROVIDER: PRJNA876378 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21411843.fastq.gz	Fastqsanger.gz
	SRR21411844_1.fastq.gz	Fastqsanger.gz
	SRR21411844_2.fastq.gz	Fastqsanger.gz
	SRR21411845_1.fastq.gz	Fastqsanger.gz
	SRR21411845_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 7

Similar Datasets

Medaka larvae were exposed to HBCD

2013-07-31 | GSE49362 | GEO

Project description:Gut microbiota in marine medaka (Oryzias melastigma)

| PRJNA610454 | ENA

Oryzias melastigma

Project description:MeDIP on the marine medaka sperm (Oryzias melastigma)

| PRJNA321309 | ENA

Medaka larvae were exposed to HBCD

Project description:Recently, omics techniques have been widely applied to the discovery of potential bio-markers and explore triggering mechanism. To get a more comprehensive diagnosis of HBCD impacts on marine medaka (Oryzias melastigma), the larvae (within 24 hours post-hatch) were exposed to gradient doses of HBCD. After exposure for 7 days, the profiles of genes expression were examined using a custom-commercial 26, 430-oligonucleotide arrays (4M-CM-^W44K) of Japanese medaka which is shared much genomic information with marine medaka.At the end of the treatment period, 30 larvae/sample were pooled for RNA extraction and labeled by One-Color. A total of twelve independent arrays: three control (DMSO), three low-concentration HBCD (0.2 nM) exposures, three medium-concentration HBCD (2 nM) exposures, and three high-concentration HBCD (20 nM) exposures. The larvae of marine medaka (within 24 hours post-hatch) were exposed to to 0 (control), 0.2nM, 2nM and 20nM of HBCD (dimethyl sulfoxide with a final concentration of 1:30000 v/v water) for 7 days. Each HBCD treatment had three replicates with 100 larvae for each Petri dish. At the end of the treatment period, 30 larvae/sample were pooled for RNA extraction. A total of twelve independent arrays: three control (DMSO), three low-concentration HBCD (0.2 nM) exposures, three medium-concentration HBCD (2 nM) exposures, and three high-concentration HBCD (20 nM) exposures.

2013-07-31 | E-GEOD-49362 | biostudies-arrayexpress

Seasonal changes of gene expression of brains (ventral part of telenchephalon, hypothalamus and pituitary) in Medaka fish (Oryzias latipes)

Project description:To examine the seasonal adaptaion, we compared the gene expression of brains (ventral part of telenchephalon, hypothalamus and pituitary) between SD (short-day conditions: 10 h light/14 h dark and 26 °C) and LD (long-day conditions: 14 h light/10 h dark and 26 °C) conditions in Medaka fish (Oryzias latipes).

2019-04-08 | GSE119837 | GEO

Seasonal changes of gene expression of eyes in Medaka fish (Oryzias latipes)

Project description:To examine the seasonal adaptation, we compared the gene expression of eyes between SL (short-day and low-temperature conditions: 10 h light/14 h dark and 8 °C) and LD (long-day and warm-temperature conditions: 14 h light/10 h dark and 26 °C) conditions in Medaka fish (Oryzias latipes).

2017-09-01 | GSE94258 | GEO

Transcriptome profile of Stage 40 Oryzias latipes (Medaka) embryos

Project description:Transcriptomic profile of Stage 40 Oryzias latipes (Medaka) embryos wild type and KO for SEDL

2024-05-03 | GSE143538 | GEO

Project description:Oryzias melastigma

| PRJNA1295022 | ENA

Project description:Polystyrene microplastic alters intestinal microbiota function and host hepatic metabolism status in marine medaka (Oryzias melastigma)

| PRJNA633960 | ENA

Modulation of medaka transcriptome by trametinib and cisplatin

Project description:We employed a transgenic strain of a small aquarium fish medaka (Oryzias latipes) that overexpresses a malignant melanoma driver gene. In this model, melanoma develops with 100 % penetrance. Using the medaka malignant melanoma model, we tested whether cisplatin and trametinib are able to suppress the transcriptomic changes induced by the transgene.

2021-05-18 | GSE114190 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data